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Enzymes produced from bacteria and eukaryotic organ-
isms are presently being used for a large variety of
different biotechnological applications. The rapidly in-
creasing demand for enzymes which are active towards
novel and often non-natural substrates has triggered the
development of novel molecular biological methods of
enzyme isolation and design. The metagenome approach
is a cultivation-independent method which allows the
direct cloning and expression of environmental DNA
thereby providing access to a wealth of so-far unknown
biocatalysts. Additionally, newly identified or existing
biocatalysts can be further optimized by different
methods of directed evolution. Here, the principle of
the metagenome approach is outlined and a strategy
is presented for the optimization of a bacterial lipase
using a combination of rational design and directed
evolution.
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INTRODUCTION
More than five thousand years ago, fermentation
was discovered as a process for the production
of alcohol. Also, without having any knowledge
of the existence of enzymes and microorganisms, the
Egyptian civilisation used yeast for baking bread, a
technique which later became known as whole
cell biocatalysis (Liese et al., 2000). A breakthrough
for using enzymes to catalyze chemical reactions
occured in 1858, when Louis Pasteur succeeded
in separating the (  /) and ( /) enantiomers of
racemic tartaric acid using the fungus Penicillium
glaucum. This experiment constitutes the first
successful biocatalytic kinetic resolution (Pasteur,
1858).
Nowadays, biocatalysis using whole cells,
crude cell extracts or purified enzymes has achieved
a position of steadily increasing importance for
the biotechnological production of food additives,
agrochemicals, cosmetics and flavours, and, in
particular, for pharmaceuticals. The rapidly growing
demand for these compounds results in a pressing
need to identify biocatalysts with novel and desired
properties. Therefore, extended programs aim to
collect novel microorganisms, plants or animals
from all over the world to use them as a source for
the identification of novel enzymes. However, nat-
ural evolution has adjusted today’s enzymes to
perfectly fit into their respective physiological
niches. As a consequence, their biochemical proper-
ties like stability, activity, and enantioselectivity
normally do not fulfill the needs of a chemical
process.
In order to overcome these difficulties, a reper-
toire of tools for enzyme engineering was devel-
oped with most of them operating in a rational
way. Firstly, the 3D-structure of a given enzyme is
solved to allow the identification of important
amino acids. Then, enzyme variants are con-
structed by classical site-directed mutagenesis
based on predictions derived from the analysis of
the 3D-structure and finally, these variants are
biochemically characterized. More recently, a set
of new methods was developed which are sum-
marized as ‘‘in vitro’’ or ‘‘directed’’ evolution and
provide a powerful tool for the creation of novel
biocatalysts whithout requiring any knowledge of
the enzyme structure or its catalytic mechanism
(Cherry and Fidantsef, 2003; Farinas et al., 2001;
Jaeger et al., 2001; Powell et al., 2001; Tao and
Cornish, 2002).
In this article we will describe promising novel
approaches to (i) identify biocatalyst genes and (ii)
optimize an enzyme by directed evolution.
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NEW BIOCATALYST GENES
Starting about 3.8 billion years ago, natural evolution
has created prokaryotes capable of coping with
adverse living conditions and inhabiting almost
every ecological niche by metabolizing virtually all
known substrates. Therefore, it is not surprising that
prokaryotes became the dominant form of life and
may represent the largest constituent of total bio-
mass on earth (Whitman et al., 1998). Despite their
abundance, current estimates indicate that more
than 99% of the prokaryotes present in natural
environments like soil, water, sediments, or plant
surfaces are not readily culturable in the laboratory
by standard techniques and therefore remain in-
accessible for biotechnological applications (Amann
et al., 1995). This fact is illustrated by the observation
that one gram of soil may contain thousands of
different species, however, only about 10 /100 dif-
ferent species will be caught by known cultivation
methods (Torsvik et al., 2002). Obviously, these
uncultivated bacteria not only significantly contri-
bute to the ecology of a bacterial community
(Torsvik and Ovreas, 2002) but they also represent
an enormous biotechnological potential (Cowan,
2000). The so-called metagenome approach (Han-
delsman et al., 1998) can overcome the cultivation
problem by direct isolation and cloning of environ-
mental DNA (eDNA) resulting in metagenome
libraries which represent the genomes of all micro-
organisms present in a given sample independent of
their culturability. The microbial diversity present in
such a library can be analysed by 16S-rRNA sequen-
cing and these libraries also constitute the starting
material to identify novel biocatalyst-encoding genes
by using high-throughput screening or selection
methods (Fig. 1).
Nevertheless, several problems exist in construct-
ing metagenome libraries. Isolated eDNA derived
from soil-samples may be contaminated with phe-
nolic compounds or humic acids which inhibit the
following cloning steps, namely the digestion cata-
lyzed by restriction endonucleases, the ligation, or
the eDNA-amplification using the polymerase chain
reaction (PCR). Several promising approaches were
described to circumvent these problems (Rochelle,
2001). Different isolation strategies are suitable to
recover the spectrum of prokaryotic diversity pre-
sent in a respective sample: (1) The ex situ methods
in which cells are isolated and concentrated from
soil prior to their lysis, and (2) the in situ methods in
which cells are lysed directly within the soil material
(Courtois et al., 2001). (3) A third strategy uses the
enrichment of microorganisms for a desired enzyme
activity prior to the isolation of metagenomic
DNA. This strategy proved successful for isolating
complete biotin operons and many different bioca-
talyst-encoding genes (Borneman, 1999; Entcheva et
al., 2001; Radajewski et al., 2000; Schmeisser et al.,
2003; Voget et al., 2003). (4) A new and elegant
approach starts with an amplification of specific
partial gene sequences using conserved and degen-
erate oligonucleotides called metagenome sequence
tags (MST?s). Subsequently, shuffling of the cloned
fragments and PCR-amplification generates biocata-
lyst genes of increased diversity as shown for
dehalogenases and haloperoxidases (Lorenz et al.,
2002). Undoubtedly, the metagenome approach will
quickly generate an enormous amount of novel
enzyme genes, however, novel tools have to be
developed to increase the efficiency of cloning and
expression.
DIRECTED EVOLUTION TO ENGINEER NOVEL
BIOCATALYSTS
Many different enzymes have been subjected to
optimization by directed evolution including pro-
teases, amylases, laccases, phytases, and cellulases
(Cherry and Fidantsef, 2003). Substrate specificity,
thermal stability, and organic solvent resistance, but
also more difficult properties such as cofactor-
independence or enantioselectivity were evolved
(Funke et al., 2003; Lingen et al., 2003; May et al.,
2000; Moore and Arnold, 1996; Wong et al., 2004,
Zhao and Arnold, 1999). In our group, a variety of
different directed evolution methods have been used
to evolve lipases which represent the most important
class of enzymes for organic chemistry (Jaeger and
Eggert, 2002; Jaeger and Reetz, 1998). In particular,
we have extensively characterized the bacterial
lipases from Pseudomonas aeruginosa and Bacillus
subtilis and have studied their structure-function
relationships by site-directed (Eggert et al., 2000;
Liebeton et al., 2001) and random mutagenesis
methods (Funke et al., 2003; Liebeton et al., 2000;
Reetz et al., 1997).
Lipases have been studied for many years, but
there is still a debate over a general definition for a
lipase and whether structural features can be
identified in lipases which govern the lipase reac-
tion or determine its specificity (Chahinian et al.,
2002b; Verger, 1997). In contrast to esterases, lipases
show almost no activity as long as the substrate is
present in the monomeric state. However, when the
solubility limit of the substrate is exceeded and an
emulsion is formed, a sharp increase in lipase
activity occurs, a phenomenon termed interfacial
activation (Sarda and Desnuelle, 1958). The first
lipase 3D structures which were solved for human
pancreatic and a fungal lipase (Brady et al., 1990;
Winkler et al., 1990) provided an elegant explanation
for this phenomenon. Both lipases were found to
140 T. EGGERT et al.possess a-helical polypeptide chains capable of
covering the active site thereby making the catalytic
amino acid residues inaccessible to substrate mole-
cules. The a-helices which were called ‘‘lid’’-struc-
tures would move upon contact with the substrate
interface resulting in conformational reorientations
which render the active site residues accessible for
the substrate. This ‘‘lid-hypothesis’’ was later con-
firmed by elucidating the X-ray structures of several
other inhibitor-bound lipases (Brzozowski et al.,
1991; Nardini et al., 2000) and has since been used
to discriminate between ‘true’ lipases and esterases
(Jaeger et al., 1999; Verger, 1997). In addition, the lid-
domain of lipases has also been identified as being
important for substrate recognition, catalytic activ-
ity, substrate specificity, (Carriere et al., 1998;
Chahinian et al., 2002a; Brocca et al., 2003), enantio-
selectivity (Liebeton et al., 2000), and activity in
organic solvents (Fishman and Cogan, 2003; Min-
garro et al., 1995). In summary, lid-like structural
elements constitute the most important structural
elements of lipases.
During the last few years, three-dimensional
structures of 26 lipases, including 8 lipases from
bacterial origin, have been elucidated (Table I).
Surprisingly, not all of these structures revealed the
presence of a lid-domain. The lipases from Bacillus
subtilis (Dartois et al., 1992; Eggert et al., 2000;
Lesuisse et al., 1993) are catalytically active on long
chain lipids although they do not possess a lid-
domain. B. subtilis lipase A (BSLA) is the smallest
lipase (181 amino acids; 19.3 kDa) known so far
which has a solvent-exposed active site located at the
bottom of a small cleft between two loops consisting
of residues 10 /15 and 131 /137. The BSLA active site
contains a preformed oxyanion hole so that con-
formational changes are not required to ensure the
formation of the transition state. Thus, its small size
and the absence of a lid make BSLA the minimal
a/b-hydrolase-fold enzyme (Fig. 2) (van Pouderoyen
et al., 2001). Therefore, we have chosen this enzyme
as a starting point to engineer by directed evolution
new lid structures on top of the existing minimal
a/b-hydrolase core.
FIGURE 1 Schematic outline of the metagenome approach to isolate novel biocatalysts. DNA representing the collective genomes of a
given habitat is PCR-ampliﬁed for prospecting biodiversity by 16S rRNA sequencing and cloned into appropriate vectors used for
identiﬁcation by DNA sequencing, expression cloning, and subsequent determination of enzyme activities, e.g. by high-throughput
screening, the novel biocatalysts may further be optimized by directed evolution.
NOVEL BIOCATALYSTS BY IDENTIFICATION AND DESIGN 141Construction of B. subtilis Lipase with an Artificial
Lid-domain
In computer-based studies the lipolytic enzymes
cutinasefromFusariumsolanipisi,acetylxylanesterase
from Penicillium purpurogenum, and human pancrea-
tic lipase were compared with respect to the domains
located close totheir activesites. These enzymeswere
chosen because their three-dimensional structures
show a high homology to the structure of BSLA.
Furthermore, lids or lid-like-domains were present in
all three X-ray structures but are missing in the
Bacillus lipase.Subsequently,theselidsweremodeled
into the structure of BSLA indicating experimental
options to engineer these lids into BSLA without
disturbing the core a/b-hydrolase fold (Fig. 3).
BSLA-variants Carrying an Artificial Lid-domain
Show Hydrolytic Activity
The lid-sequences were engineered into the BSLA-
gene by using a modified two-step megaprimer PCR
method. The resulting BSLA-variants (Fig. 3) were
overexpressed in E. coli and tested for enzymatic
activity with the substrates p-nitrophenyl palmitate
(spectrophotometric assay, Fig. 4A) and tributyrin
(agar plate assay, Fig. 4B). All variants showed
enzymatic activity, at least against one of the sub-
strates, although the variants containing artificial lid
domains exhibited a lower activity than the wild-
type. Therefore, we are currently trying to optimize
the artificial lid domains by subjecting the corre-
sponding DNA-fragments to random mutagenesis
using ep-PCR. Preliminary results with a high-
throughput screening assay on tributyrin indicator
plates indicated that we have created several new
variants which exhibit wild-type activities.
OUTLOOK
Enzyme-based biocatalysis provides a means to
carry out chemical processes efficiently and econom-
ically. This fact is increasingly recognized as re-
flected by a rapidly growing enzyme market which
was valued at approximately $1.5 billion already in
2000 (Cherry and Fidantsef, 2003) and is expected to
increase by an average annual growth rate of at least
10%. The future success of enzyme technology will
depend on the development of efficient and cost-
effective processes for the production and down-
stream processing of enzymes. Even more important
will be the identification of novel enzyme genes
from natural sources, their high-level and functional
expression, as well as their optimization for desired
properties by directed evolution. The combination of
these methods will undoubtedly result in a major
breakthrough for enzyme technology, also in entirely
new areas of technical applications.
Acknowledgements
This work was supported by the German Bundes-
ministerium fu ¨r Bildung und Forschung (Compe-
tence Network ‘‘Genome Research on Bacteria for
the Analysis of Biodiversity and Its Further Use
for the Development of New Production Pro-
TABLE I Overview of solved three-dimensional structures of
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FIGURE 2 Crystal structure of B. subtilis lipase A (BSLA). The
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active site are labelled with A (b4 and aB) and B (b8 and aF),
respectively.
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